Compare FormFactor Inc. FormFactor Inc. Common Stock (FORM) vs Immunovant Inc. Common Stock (IMVT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
FormFactor Inc. FormFactor Inc. Common Stock vs Immunovant Inc. Common Stock — how do they compare? FormFactor Inc. FormFactor Inc. Common Stock trades at $141.38 (market cap $10.92B), while Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B). The key difference: FormFactor Inc. FormFactor Inc. Common Stock is the larger of the two by market cap, and FormFactor Inc. FormFactor Inc. Common Stock is trading nearer its 52-week high, Immunovant Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold FormFactor Inc. FormFactor Inc. Common Stock for 0 Days and Immunovant Inc. Common Stock for 0 Days on average.
| FORM | IMVT | |
|---|---|---|
Market Cap | $10.92B | $6.62B |
Volume | 1,056,924 | 1,131,364 |
Sector | Technology | Health |
52-Week High | $159.93 | $44.96 |
52-Week Low | $38.14 | $17.03 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.61B | $5.72B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About FormFactor Inc. FormFactor Inc. Common Stock
FormFactor, Inc. provides semiconductor test and measurement technologies used across the integrated circuit lifecycle, manufacturing probe cards and analytical probes through its Probe Cards segment and probe stations, thermal systems, and cryogenic systems through its Systems segment.
Read more on FORM →About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →
